Abbott Laboratories Shares Down 16% as Analyst Projects 35% Upside

Abbott Laboratories has seen its share price decline by 16% this year amid broader market fluctuations affecting the healthcare sector.

Despite the recent drop, one market analyst projects a significant turnaround for the company, forecasting potential gains of up to 35%.

The projections come as market participants continue to monitor overall performance metrics and growth prospects across the healthcare giant's key operating divisions.